Shortage of Novo's Wegovy and Ozempic is resolved, FDA website shows - Watch Healthcare Equity Strategist on Novo Setback - Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready To Meet Demand? - Novo CEO to blame drug middlemen - Novo's Wegovy Puts a Higher Price on Heart Health in the US - Lilly Gains in Obesity Race With Novo as Supplies Expand - Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says - Novo Won't Meet Wegovy Demand in Short-Medium Term: CFO - Wegovy maker Novo inks $16.5 billion acquisition of Catalent to boost supply - Why Obesity Drug Coverage Doesn't Matter (Yet) for Lilly and Novo

Novo

6 days ago

Bookmark

Share

Novo is a company. It is located in Middlesex, the United States and was founded in 2016.

Key facts

city: Middlesex
country: United States
foundation year: 2016

Classified as: organization

LinkedIn: 9K followers

X (Twitter): 3K followers

Business

Novo is one of the companies in the United States and 3,550,070 companies in our database.

Employees: Try Pro to see estimates
Revenues: Try Pro to see estimates

Stocks from Novo:

Talking Points

Online Business Banking Solutions | Novo
Novo is an online business banking platform with no hidden fees built for small business owners. Apply for a free Novo checking account.
The powerfully simple, award-winning banking platform for small businesses. Powered by Middlesex Federal Savings. Home of the #SmallBusinessBrave
Powerfully simple business banking with no hidden fees - built for small business owners, freelancers, and entrepreneurs | Novo is a banking platform that ...

Learn more about talking points

In literature

There is no book written about Novo in the database.

Related

Connected or similar to Novo:

Details

This dashboard is based on data from: YAHOO-FIN, YFINANCE, Twitter.

This content is available under the CC BY 4.0 license.